¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Journal. National Malaria Society."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malariae malaria
    »çÀÏ¿­¸»¶ó¸®¾Æ
  • ovale malaria
    ³­Çü¿­¸»¶ó¸®¾Æ
  • pernicious malaria
    ¾Ç¼º¸»¶ó¸®¾Æ
  • quartan malaria
    »çÀÏ¿­¸»¶ó¸®¾Æ
  • quotidian malaria
    ¸ÅÀÏ¿­¸»¶ó¸®¾Æ
  • vivax malaria
    »ïÀÏ¿­¸»¶ó¸®¾Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • introduced malaria
    µµÀÔ¸»¶ó¸®¾Æ
  • malaria
    ¸»¶ó¸®¾Æ, ÇÐÁú
  • malaria periodicity
    ¸»¶ó¸®¾ÆÁֱ⼺
  • malaria patent period
    ¸»¶ó¸®¾ÆÇö¼º±â°£
  • malaria reproduction rate
    ¸»¶ó¸®¾ÆÀç»ý»êÀ²
  • malariae malaria
    »çÀÏ¿­¸»¶ó¸®¾Æ
  • ovale malaria
    ³­Çü¿­¸»¶ó¸®¾Æ
  • pernicious malaria
    À¯Çظ»¶ó¸®¾Æ
  • quartan malaria
    (¢¡malariae malaria) »çÀÏ¿­¸»¶ó¸®¾Æ
  • quotidian malaria
    ¸ÅÀÏ¿­
  • tertian malaria
    »ïÀÏ¿­¸»¶ó¸®¾Æ
  • triple quartan malaria
    »ïÁß»çÀÏ¿­¸»¶ó¸®¾Æ
  • vivax malaria
    »ïÀÏ¿­¸»¶ó¸®¾Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malaria
    ¸»¶ó¸®¾Æ
  • malaria biliaris ³ª
    ´ãÁó¼º(ÓÅ àõ) ¸»¶ó¸®¾Æ.
  • malaria chronica ³ª
    ¸¸¼º(Ø·àõ)¸»¶ó¸®¾Æ.
  • malaria comatosa ³ª
    È¥¼ö¼º(ûçâ²àõ) ¸»¶ó¸® ¾Æ.
  • malaria control
    ¸»¶ó¸®¾Æ°ü¸®(ÊÙË´Ëö).
  • malaria intermittens ³ª
    °£Çæ¿­(ÊàúÎæð)¸»¶ó ¸®¾Æ.
  • malaria perniciosa ³ª
    ¾Ç¼º(ç÷àõ)¸»¶ó¸®¾Æ.
  • malaria quartana ³ª =malarial m.
    »çÀÏ¿­ (ÞÌìíæð)¸»¶ó¸®¾Æ.
  • malaria quotidiana ³ª
    ¸ÅÀÏ¿­(Øßìíæð)¸»¶ó¸® ¾Æ.
  • malaria tertiana perniciosa
    ¾Ç¼º»ïÀÏ¿­(ç÷ àõß²ìíæð)¸»¶ó¸®¾Æ.
  • malaria tertiana ³ª
    »ïÀÏ¿­(ß²ìíæð)¸»¶ó¸®¾Æ.
  • malaria therapy
    ¸»¶ó¸®¾Æ¿ä¹ý(¡­èþÛö).
  • malaria vector
    ¸»¶ó¸®¾Æ¸Å°³Ã¼
  • malarial malaria
    »çÀÏ¿­(ÞÌìíæð)¸»¶ó¸®¾Æ.
  • malignant malaria
    ¾Ç¼º¸»¶ó¸®¾Æ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
JOC Journal of Oncologic Clinical(?)
AEM Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph...
AM Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ...
BMJ bones, muscles, joints; British Medical Journal
BTM benign tertian malaria; body or blood temperature monitor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ABS American Brachytherapy Society
ACS American Cancer Society
ASTM American Society for Testing and Materials
ASTRO American Society for Therapeutic Radiology and Oncology
ASA American Society of Anaesthesiologist
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malaria
    ÇÐÁú, ¸»¶ó¸®¾Æ
    1. ¸»¶ó¸®¾Æ´Â Plasmodium viviax
  • malaria algid
    ÇѼº ¸»¶ó¸®¾Æ
    ¸»ÃÊ Ç÷°ü ºÎÀüÀ» Ư¡À¸·Î ÇÏ´Â ¿­´ë¼º ¸»¶ó¸®¾Æ·Î¼­ ÇǺγð¨, ¼è¾à, À§ Àå°ü ¹× ±× ¿ÜÀÇ º¹°­³» Àå±â Ç÷°üÀÇ ±¤¹üÇÑ Ä§½ÀÀ» ¼ö¹ÝÇÑ´Ù.
  • malaria bilious remittent
    ´ãÁó¼º ÀÌÀ强 ¸»¶ó¸®¾Æ
    ¹ßº´ ÈÄ Á¦ 2Àϰ濡 ³ªÅ¸³ª´Â ½ÉÇÑ ±¸¿ª, Áö¼Ó¼º ±¸Åä, ÀÌÀ强 °í¿­, Ȳ´ÞÀ» Ư¡À¸·Î ÇÏ´Â ¿­´ë¼º ¸»¶ó¸®¾ÆÀÇ ¾Ç¼º ÇüÅÂ.
  • malaria cerevra
    ³ú¼º ¸»¶ó¸®¾Æ
    ±â»ýÃæÀÌ ³ú¿¡ ±¹ÇÑµÇ¾î ±× °á°ú ¼¶¸Á, È¥¼ö¸¦ ¼ö¹ÝÇÏ´Â ¿­´ë¼º ¸»¶ó¸®¾Æ.
  • malaria hemolysis
    ¿ëÇ÷¼º ¸»¶óÀ̾Æ
  • malaria induce
    À¯¹ß¼º ¸»¶ó¸®¾Æ
    ½Å°æ ¸Åµ¶ Ä¡·á¿¡ ¶§¶§·Î »ç¿ëµÇ¾ú´ø °Íó·³, º´¿ø¼º ±â»ýÃæÀ» °íÀÇ·Î °¨¿°½ÃÄѼ­ À¯¹ßµÈ ¸»¶ó¸®¾Æ.
  • malaria ovale
    ³­Çü¼º ¸»¶ó¸®¾Æ
    Plasmodium ovale °¨¿°¿¡ ÀÇÇØ¼­ ÀϾ´Â °¡º­¿î ÁúȯÀ¸·Î¼­, º¸Åë ¸î ¹øÀÇ ±ÔÄ¢ÀûÀ¸·Î Àç¹ßµÇ´Â 3ÀÏ ¿­ ¹ßÀÛÀ» Ư¡À¸·Î ÇÑ´Ù. °æÁ÷À» ÀÏÀ¸Å°´Â ÀüÇüÀûÀÎ 3ÀÏ ¿­ ¸»¶ó¸®¾Æ¿Í´Â ´Þ¸® ¿ÀÇÑ, ÀüÀ²·Î ½ÃÀÛÇÏ¿© ÀÚ¿¬ Ä¡À¯µÇ´Â °æÇâÀÌ ÀÖ´Ù.
  • malaria quarta
    »çÀÏ ¿­ ¸»¶ó¸®¾Æ
    ¹ß¿­ ¹ßÀÛÀÌ 72½Ã°£¸¶´Ù, ¶Ç´Â ¹ß»ý ÀÏÀ» °¢ ÁÖ±âÀÇ Á¦ 1ÀÏ·Î °è»êÇÏ¿© 4Àϸ¶´Ù ÀϾ´Â °Í. º´¿øÃ¼´Â Plasmodium malariae·Î¼­ À̰ÍÀº ÀûÇ÷±¸³»¿¡¼­ °¢ ¹«¼º »ý½Ä ȯÀ» ¿Ï·áÇÏ´Â µ¥ 72½Ã°£À» ¿äÇÑ´Ù.
  • malaria subtertia
    ¾Æ»ïÀÏ ¿­ ¸»¶ó¸®¾Æ
  • malaria transfusion
    ¼öÇ÷ ¸»¶ó¸®¾Æ
    ¿À¿°µÈ ÁÖ»ç ¹Ù´ÃÀÇ ¿ì¹ßÀû °¨¿°À̳ª, ÁÖ»ç ¹Ù´ÃÀ» °øµ¿À¸·Î »ç¿ëÇÏ´Â ¾à¹° Ž´ÐÀÚ¿¡ ÀÇÇØ¼­ °øÇ÷ÀڷκÎÅÍ Á÷Á¢ ÀüÆÄµÇ´Â Plasmodium malariae, Plasmodium vivax, Plasmodium ovaleÀÇ °¨¿°.
  • malaria-typhoid
    ¸»¶ó¸®¾Æ ŸÀÌÆ÷À̵å
  • pernicious malaria
    ¾Ç¼º ¸»¶ó¸®¾Æ
  • quartan malaria
    »çÀÏ ¿­ ¸»¶ó¸®¾Æ
  • tertian malaria
    »ïÀÏ ¿­ ¸»¶ó¸®¾Æ
    ¹ßÇöÇÏ´Â ³¯À» ù ¹øÂ° ³¯·Î Çϰí 3Àϰ¿¡ Àç¹ßÇÏ´Â ¸»¶ó¸®¾Æ ¿øÃæ¿¡ ±âÀÎÇÏ´Â ¿­º´.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
national practitioner data bank A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.
(12 Dec 1998)
National Science Foundation <organisation> A nonregulatory U.S. Federal agency which has oversight of biotechnology research activities that the agency funds.
(09 Oct 1997)
united states national aeronautics and space administration An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles.
(12 Dec 1998)
los alamos national laboratory <radiobiology> Major DOE research facility, located in Los Alamos, new Mexico, about an hour west of Santa Fe. Former home of a frozen-deuterium-fibre Z-pinch device, which was dismantled. Home to an active theory division, including the Numerical Tokamak Grand Challenge (being performed on the CM-5 massively-parallel supercomputer). Also home to former alternative-concepts experimental devices like Scyllac, FRX-A, FRX-B, FRX-C/LSM, ZT40, and the aborted CPRF which was killed in 1991 when it was almost complete (budget cuts). Currently there are some small in-house experiments, including one on electrostatic confinement as a possible fusion device, and/or a compact neutron source. They also do theory and experimental collaboration with other labs worldwide.
(09 Oct 1997)
acute malaria A form of malaria that may be intermittent or remittent, consisting of a chill accompanied and followed by fever with its attendant general symptoms, and terminating in a sweating stage; the paroxysms, caused by release of merozoites from infected cells, recur every 48 hours in tertian (vivax or ovale) malaria, every 72 hours in quartan (malariae) malaria, and at indefinite but frequent intervals, usually about 48 hours, in malignant tertian (falciparum) malaria.
(05 Mar 2000)
algid malaria A form of falciparum malaria chiefly involving the gut and other abdominal viscera; gastric algid malaria is characterised by persistent vomiting; dysenteric algid malaria is characterised by bloody diarrheic stools in which enormous numbers of infected red blood cells are found.
(05 Mar 2000)
autochthonous malaria Disease acquired by mosquito transmission in an area where malaria regularly occurs.
(05 Mar 2000)
avian malaria <veterinary> Plasmodial infections of domestic and wild birds, transmitted chiefly by culicine mosquitoes.
(05 Mar 2000)
benign tertian malaria <disease, microbiology> A type of malaria caused by the protozoan Plasmodium vivax, it isthe most common form of the disease, is rarely fatal but is the most difficult to cure, and is characterised by fevers that typically occur every other day.
(11 Nov 1997)
bilious remittent malaria A form of falciparum malaria characterised by bilious vomiting, bilious diarrhoea, etc.
(05 Mar 2000)
malaria In humans, the set of diseases caused by infection by the protozoans Plasmodium vivax causing the tertian type, P. Malariae the quartan type and P. Falciparum the quotidian or irregular type of disease, the names referring to the frequency of fevers. The fevers occur when the merozoites are released from the erythrocytes. The organisms are transmitted by the Anopheles mosquito.
(18 Nov 1997)
malaria, avian Any of a group of infections of fowl caused by protozoa of the genera plasmodium, leucocytozoon, and haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.
(12 Dec 1998)
malaria, cerebral A condition that is most commonly seen as a severe complication of malaria, falciparum mainly involving the brain. It has also been reported to occur as a result of infection with other plasmodium species. This disease is often fatal and presents as disturbances in consciousness ranging from somnolence to coma, major motor seizures, and organic psychosis. The onset may be gradual or sudden following a convulsion.
(12 Dec 1998)
malaria comatosa Falciparum malaria complicated by coma.
(05 Mar 2000)
malariae malaria A malarial fever with paroxysms that recur every 72 hours or every fourth day, reckoning the day of the paroxysm as the first; due to the schizogony and release of merozoites from infected cells, with invasion of new red blood corpuscles by Plasmodium malariae.
Synonym: quartan fever, quartan malaria.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • benefit society
    °øÁ¦Á¶ÇÕ
  • cafe society
    (ƯÈ÷ New York½ÃÀÇ)ÀÏ·ù Ä«ÆäÀÇ ´Ü°ñ ¼Õ´Ôµé
  • cashless society
    Çö±ÝÀÌ ºÒÇÊ¿äÇÑ »çȸ(Å©·¹µðÆ® Ä«µåÀÇ »ç¿ë,ÀºÇàÀÇ ÀÚµ¿ ºÒÀÔ¿¡ ÀÇÇÑ)
  • checkless society
    (Å©·¹µðµå Ä«µå »ç¿ë,ÀºÇà ÀÚµ¿ ºÒÀÔ µî¿¡ ÀÇÇÑ)½Å¿ë »çȸ;Çö±Ý ºÒ¿ä »çȸ
  • classification society
    ¼±±Þ Çùȸ(»ó¼±ÀÇ µî±ÞÀ» ¸Å±â´Â)
  • cooperative society
    Çùµ¿Á¶ÇÕ(¼ÒºñÀÚ.»ý»êÀÚµîÀÇ)
  • debating society club
    Åä·Ðȸ
  • folk society
    ¹Î¼Ó »çȸ(ÀÛ°í °í¸³ÇÏ¿© µ¿Áú¼ºÀ» °®°í °á¼ÓÀÌ °­ÇÑ Áö¿ª »çȸ)
  • fraternal society
    ¿ì¾Ö Á¶ÇÕ
  • friendly society
    =BENEFIT SOCIETY
  • high society
    »ó·ù »çȸ
  • honor society
    Çо÷ ¼ºÀû ÀÎÁ¤ À§¿øÈ¸;¿ìµî»ý »ç±³ Ŭ·´
  • informationintensive society
    Á¤º¸(È­)»çȸ
  • mass society
    ´ëÁß »çȸ(»ê¾÷È­,µµ½ÃÈ­µÈ Çö´ë »çȸ)
  • me society
    ÀÚ±â Á᫐ »çȸ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á